연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2635. Gene-environment interaction relevant to estrogen and risk of breast cancer: Can gene-environment interaction be detected only among candidate SNPs from GWAS?
JooYong Park 1 2, Ji-Yeob Choi 1 2 3 4, Jaesung Choi 3, Seokang Chung 1, Nan Song 5, Sue K Park 1 4 6, Wonshik Han 4 7, Dong-Young Noh 4 7, Sei-Hyun Ahn 8, Jong Won Lee 8, Mi Kyung Kim 9, Sun Ha Jee 10, Wanqing Wen 11, Manjeet K Bolla 12, Qin Wang 12, Joe Dennis 12, Kyriaki Michailidou 12 13 14, Mitul Shah 15, Don M Conroy 15, Patricia A Harrington 15, Rebecca Mayes 15, Kamila Czene 16, Per Hall 16 17, Lauren R Teras 18, Alpa V Patel 19, Fergus J Couch 19, Janet E Olson 20, Elinor J Sawyer 21, R
Cancers 13 (10), 2370
Link
2634. Network of biomarkers and their mediation effects on the associations between regular exercise and the incidence of cardiovascular & metabolic diseases
JY Park, J Choi, JE Kim, M Lee, A Shin, J Lee, D Kang, JY Choi
Scientific reports 11 (1), 1-11
Link
2633. Relative effects of demographic, psychological, behavioral, and social factors on the initiation and maintenance of leisure-time physical activity: Results from a confirmatory path analysis in a longitudinal study. Journal of Epidemiology
J Choi, JY Park, JE Kim, J Lee, D Kang, M Lee, IJ Chung, JY Choi
Journal of epidemiology 31 (11), 557-565
Link
2632. Local adenoviral delivery of soluble CD200R-Ig enhances antitumor immunity by inhibiting CD200-β-catenin-driven M2 macrophage.
Shin SP, Goh AR, Ju JM, Kang HG, Kim SJ, Kim JK, Park EJ, Bae YS, Choi K, Jung YS, Lee SJ.
Mol Ther Oncolytics. 2021 Dec 17;23:138-150.
Link
2631. Head to head comparison of 68Ga-NGUL and 68Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study.
Suh M, Im HJ, Ryoo HG, Kang KW, Jeong JM, Kumar S, Ballal SS, Yadav MP, Bal C, Jeong CW, Kwak C, Cheon GJ
J Nucl Med 2021; 62:1457-1460
Link
2630. Multi-quantum dots-embedded silica-encapsulated nanoparticle-based lateral flow assay for highly sensitive exosome detection
Kim HM, Oh C, Ahn J, Baek S, Bock S, Kim J, Jung HS, Song H, Kim JW, Jp A, Kim DE, Rho WY, Jang JY, Cheon GJ, Im HJ, Jun BH
Nanomaterials 2021; 11:768
Link
2629. Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts
Na D, Chae J, Cho SY, Kang W, Lee A, Min S, Kang J, Kim MJ, Choi J, Lee W, Shin D, Min A, Kim YJ, Lee KH, Kim TY, Suh YS, Kong SH, Lee HJ, Kim WH, Park H, Im SA, Yang HK, Lee C, Kim JI.
Nat Commun. 2021 Aug 10;12(1):4840
Link
2628. CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers
Jung HR, Oh Y, Na D, Min S, Kang J, Jang D, Shin S, Kim J, Lee SE, Jeong EM, An JY, Sung CO, Lee WS, Lee C, Cho SY
Oncogene. 2021 May;40(18):3287-3302
Link
2627. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice.
Lee SH, Cho SY, Yoon Y, Park C, Sohn J, Jeong JJ, Jeon BN, Jang M, An C, Lee S, Kim YY, Kim G, Kim S, Kim Y, Lee GB, Lee EJ, Kim SG, Kim HS, Kim Y, Kim H, Yang HS, Kim S, Kim S, Chung H, Moon MH, Nam MH, Kwon JY, Won S, Park JS, Weinstock GM, Lee C, Yoon KW, Park H
Nat Microbiol. 2021 Mar;6(3):277-288
Link
2626. Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers.
Oh Y, Jung HR, Min S, Kang J, Jang D, Shin S, Kim J, Lee SE, Sung CO, Lee WS, Lee C, Jeong EM, Cho SY
Cancer Lett. 2021 Jan 28;497:123-136
Link